Inhaled nitric oxide in fibrotic and advanced interstitial lung disease: A systematic review and meta-analysis of randomized controlled trials

Shun Nakahara, Yusuke Hirao, Bradley Fujiuchi, Brent Matsuda · 2026

Read Inhaled nitric oxide in fibrotic and advanced interstitial lung disease: A systematic review and meta-analysis of randomized controlled trials by Shun Nakahara, Yusuke Hirao, Bradley Fujiuchi, Brent Matsuda (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0351862.txt.

Description

Shun Nakahara and colleagues pooled the randomized trials of inhaled nitric oxide for people with fibrotic lung disease, a scarring condition that raises pressure in the lung's arteries and steals exercise capacity. The gas relaxes those arteries when breathed, so it was a plausible help. Four trials with two hundred seventy-four patients, some crossing over between gas and placebo, were combined, with walking distance in six minutes as the main yardstick.

The pooled result was a near-perfect shrug: walking distance barely differed from placebo, everyday activity levels did not clearly improve, and side effects were no worse. The authors conclude the evidence does not support routine use in this population. Negative meta-analyses save real money and hope: clinics can stop spending on a treatment whose trials, gathered honestly, do not deliver.

Catalog record

CREATORShun Nakahara, Yusuke Hirao, Bradley Fujiuchi, Brent Matsuda
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE24803
LICENSECC_BY
RIGHTSCC BY
SOURCEPLOS

Source: https://doi.org/10.1371/journal.pone.0351862

Browse the full library · About the Tower of Babel